Autolus Inc
UnclaimedPharmaceutical Preparation ManufacturingGaithersburg, MD
Founded
2017
Primary NAICS
325412
CAGE code
9Z0X0
Federal awards
$401K
Overview
Autolus is a CAR T cell therapy company which develops advanced autologous T cell therapies that have the potential to deliver life-changing benefits to patients with cancer and autoimmune diseases
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 1 |
| 2025 | Department of Veterans Affairs | $401,005 | 4 |